BeStock  
Stocks › HALO

Halozyme Therapeutics HALO

US equityMarket cap rank #776
$108.92 −$1.49 (-1.35%)
Market open · Oct 1, 3:30 pm ET · After hours $110.00 -0.36%
Open$109.93
Prev close$110.40
Day range$107.86 – $110.49
Volume1.48M
Market cap$12.36B
P/E (TTM)31.9
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership110.8%+0.28 pts vs. prior quarter
Institutions holding800-5 vs. prior quarter

The five largest holders on file together own 28.8% of shares outstanding.

Largest holders

  • BlackRock11.69%
  • Vanguard Capital Management, LLC5.39%
  • Vanguard Portfolio Management, LLC4.67%
  • State Street Global Advisors4.56%
  • Boston Partners Global Investors, Inc.2.44%
  • Invesco Ltd.2.31%
  • William Blair Investment Management, LLC2.27%
  • Geode Capital Management, LLC2.22%

By investor type

  • Mutual Fund87.23%
  • Public Company8.99%
  • Hedge Fund7.17%
  • Government Pension Fund2.66%
  • Private Company2.59%
  • Sovereign Wealth Fund1.31%
  • Individual/Insider1.06%
  • Family Office/Trust0.48%

No ownership data on file for this stock.

Discussion

No comments yet — be the first to weigh in on HALO.

Leave a comment

Scroll to Top